Disposition of a novel and potent α_vβ₃ antagonist in animals, and extrapolation to man

By Prueksaritanont T.   Fernandez-Metzler C.   Meng Y.   Barrish A.   Halczenko W.   Rodan S. B.   Hutchinson J. H.   Duggan M. E.   Lin J. H.  

Xenobiotica, Vol. 34, Iss. 1, 2004-01 ,pp. : 103-115

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of TR-14035, a novel antagonist of 4β1/4β7 integrin mediated cell adhesion, in rat and dog

By Tsuda-Tsukimoto M.   Ogasawara Y.   Kume T.  

Xenobiotica, Vol. 35, Iss. 4, 2005-04 ,pp. : 373-389

Informa Healthcare

Access to resources Recommend Favorite

Identification of a Potent and Nonpeptidyl CCR3 Antagonist

By Saeki T.   Ohwaki K.   Naya A.   Kobayashi K.   Ishikawa M.   Ohtake N.   Noguchi K.  

Biochemical and Biophysical Research Communications, Vol. 281, Iss. 3, 2001-03 ,pp. : 779-782

Elsevier

Access to resources Recommend Favorite

Characterization of the Novel Murine Monoclonal Anti-von Willebrand Factor (vWf) Antibody GUR76-23 Which Inhibits vWf Interaction with alpha IIb beta 3 but Not alpha v beta 3 Integrin

By Yokoyama K.   Handa M.   Oda A.   Katayama M.   Fujimura Y.   Murata M.   Kawai Y.   Watanabe K.   Ikeda Y.  

Biochemical and Biophysical Research Communications, Vol. 234, Iss. 1, 1997-05 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite

Annexin-V Binds to the Intracellular Part of the β₅ Integrin Receptor Subunit

By Andersen M.H.   Berglund L.   Petersen T.E.   Rasmussen J.T.  

Biochemical and Biophysical Research Communications, Vol. 292, Iss. 2, 2002-03 ,pp. : 550-557

Elsevier

Access to resources Recommend Favorite